Live Free or Die Legal
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 326-B:14-a · Scope of Practice; Certified Assisted Living Medication Aide

Title
XXX: OCCUPATIONS AND PROFESSIONS
Chapter
326-B · NURSE PRACTICE ACT
Status
current
Official source linked
Yes
Official source Copy section link

326-B:14-a Scope of Practice; Certified Assisted Living Medication Aide. –

Copy link
I.

A certified assisted living medication aide (CALMA) shall practice under the supervision of the administrator of the licensed facility and have access to clinical consultation 24 hours a day appropriate for the setting in accordance with regulations established pursuant to RSA 326-B:4, I.

Copy link
II.

A CALMA is responsible for competency in the CALMA education program curriculum approved by the board.

Copy link
III.

A CALMA is authorized to administer non-injectable medication if:

Copy link
(a)

The individual holds a currently valid certificate of completion from a board-approved CALMA education program; and

Copy link
(b)

The persons served are in a residential setting as defined in RSA 151:9, VII(a)(1) and (2).

Copy link
IV.

After successful completion of the CALMA education program, a CALMA shall be able to:

Copy link
(a)

Apply knowledge and techniques in the practice of medication administration;

Copy link
(b)

Communicate effectively with the administrator and other health care professionals concerning the administration of medication;

Copy link
(c)

Maintain safe and effective methods of medication administration; and

Copy link
(d)

Maintain records as directed by the administrator of the facility.

Copy link
V.

Any expansion of the scope of practice shall be adopted by legislation in accordance with RSA 332-G:6. Source. 2024, 344:3, eff. Oct. 1, 2024.

Copy link

Source note

Source. 2024, 344:3, eff. Oct. 1, 2024.

Source history

  • 2024, 344:3, eff. Oct. 1, 2024

Related materials

Bill relationships

  • 2026 HB1321 reference

    cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ

  • 2026 HB1796 reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 HB1796-FN reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 SB453 reference

    d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e

  • 2025 HB254 reference

    tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde